Let us help you reduce the rate of SSI in your organisation
Find out more about our dressings and put our solutions for post surgical care to the test
Leukomed® Sorbact® is an innovative surgical post-operative film dressing which has a purely physical mode of action, that reduces bacterial colonisation. The dressing has demonstrated proven effectiveness in various clinical studies 1,2
- Clinically significant 65% relative risk reduction of acquiring a surgical site infection post-caesarean section 1
- Up to 57% cost reduction when treating caesarean sections, using NHS cost model 3
- Effective reduction of the bacterial burden in colonised or locally infected wounds 4
New medical technologies guidance from NICE recommends that Leukomed Sorbact should be considered as an option for preventing surgical site infection (SSI ) in wounds with low to moderate exudate post caesarean and vascular surgery and that it should be used as part of usual measures to help reduce the risk of SSI*
To read the full guidance please visit NICE website here.
*© NICE 2021 Leukomed Sorbact for preventing surgical site infection. Access here. All rights reserved. Subject to Notice of rights. NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.
Maternity: Leukomed Sorbact
A post-operative dressing with a purely physical mode of action, used to prevent SSI in closed surgical wounds after a caesarean section. Learn more here.
Medical references
1 Stanirowski J, Bizon M, Cendrowski K, et al (2016b) Randomized controlled trial evaluating dialkylcarbamoyl chloride impregnated dressings for the prevention of surgical site infections in adult women undergoing caesarean section. Surg Infect (Larchmt) 17(4): 427 -35.
2 Bua N, et al. Dialkylcarbamoyl Chloride Dressings in the Prevention of Surgical Site Infections after Nonimplant Vascular Surgery. Ann Vasc Surg. 2017 Oct:44:387-392.
3 Stanirowski PJ, Davies H, McMaster J, Mealing S, Sawicki W, Cendrowski K, Posnett J. Cost-effectiveness of a bacterial-binding dressing to prevent surgical site infection following caesarean section. Journal of Wound Care. 2019 Apr 2;28(4):222-228.
4 Cutting K, Maguire J (2015) Safe bioburden management. A clinical review of DACC technology. Journal of Wound Care Vol 24, No 5.
2 Bua N, et al. Dialkylcarbamoyl Chloride Dressings in the Prevention of Surgical Site Infections after Nonimplant Vascular Surgery. Ann Vasc Surg. 2017 Oct:44:387-392.
3 Stanirowski PJ, Davies H, McMaster J, Mealing S, Sawicki W, Cendrowski K, Posnett J. Cost-effectiveness of a bacterial-binding dressing to prevent surgical site infection following caesarean section. Journal of Wound Care. 2019 Apr 2;28(4):222-228.
4 Cutting K, Maguire J (2015) Safe bioburden management. A clinical review of DACC technology. Journal of Wound Care Vol 24, No 5.